pasitheaclinics.com (KTTA): Forvard narx/daromad multiplikatori
Pasithea Therapeutics ruhiy buzilishlarga qarshi kurashish uchun RNK terapiyalarini ishlab chiqishga e'tibor qaratadi. GURU.Markets xizmati ushbu grafikni taqdim etadi, unda forward P/S ko'rsatkichi tebranishlarni namoyish etmoqda, 39.40 belgisi esa joriy baholash darajasini ko'rsatadi. Geopolitika xalqaro sinovlar va reagentlar xaridiga to'sqinlik qilmoqda, daromadlilikning yo'qligi va ventura kapital investitsiyalariga bog'liqlik esa kompaniyani narxlarni belgilash imkoniyatidan mahrum qilmoqda.
KTTA (Pasithea Therapeutics Corp): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Pasithea Therapeutics|KTTA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics|KTTA - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Pasithea Therapeutics|KTTA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Pasithea Therapeutics|Tezkor likvidlik koeffitsiyenti pasitheaclinics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
KTTA - Kompaniyaning sof daromadi|Kelajakdagi foyda Pasithea Therapeutics|KTTA - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Pasithea Therapeutics Corp.|KTTA - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Pasithea|KTTA - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) Pasithea Therapeutics|KTTA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi pasitheaclinics.com|KTTA - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Pasithea Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahlili:Pasithea Therapeutics KTTA
Forward P/S biznesning bozor qiymatini kutilayotgan savdo hajmi bilan nisbatda belgilaydi va bu kelajakdagi pul oqimlari uchun to'langan premiumni baholash imkonini beradi. Forward P/S tendentsiyasini tahlil qilish orqali investor Pasithea Therapeutics (KTTA) kompaniyasining baholanishidagi spekulyativ tabiatni ko'rishi mumkin, chunki ushbu kompaniyaning kapitalizatsiyasi barqaror daromadning haqiqiy mavjudligiga emas, balki neyropsixiatrik klinik sinovlardan kutilayotgan ventura umidlariga asoslangan.
Pasithea Therapeutics raqobatchilari
Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati cyclerion.com CYCN|Forvard P/S multiplikatori PTIX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori
